{"id":198,"date":"2014-02-03T04:01:38","date_gmt":"2014-02-03T04:01:38","guid":{"rendered":"https:\/\/docneuro.jz7sunfr-liquidwebsites.com\/adem\/"},"modified":"2019-12-30T22:18:26","modified_gmt":"2019-12-30T22:18:26","slug":"adem","status":"publish","type":"post","link":"https:\/\/docneuro.com\/adem\/","title":{"rendered":"ADEM"},"content":{"rendered":"
ADEM (acute disseminated encephalomyelitis) is an autoimmune demyelinating disorder distinct from multiple sclerosis<\/a> or Devic’s disease.<\/p>\n <\/p>\n Figure:<\/strong> Axial FLAIR at the level of the midbrain (A) and the thalamus (B) demonstrate increased signal in the left anteromedial thalamus (red arrow) and ventral midbrain (white arrow). Axial postcontrast T1 demonstrates no enhancement of the thalamic signal abnormality (the midbrain abnormality also did not enhance but is not shown).<\/p>\n Discussion:<\/strong><\/p>\n The vast majority of ADEM cases occur after infection (~95%) or vaccination (~5%), with onset typically between a few days and a few weeks. A variety of infectious agents have been implicated, consistent with\u00a0 an autoimmune basis.<\/p>\n Unlike MS, ADEM does not typically involve the calloseptal interface (the inferior surface of the corpus callosum immediately adjacent to the septum) and it often involves the deep grey matter (thalamus, basal ganglia, dentate etc).<\/p>\n Demographically, ADEM has a slight male predominance (unlike MS) and occurs in a younger age group, typically under 8 years old but any age is possible.<\/p>\n<\/p>\n